MDA-9/Syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells

Journal of Biological Chemistry

Volumn 290, Issue 6, 2015, Pages 3333-3348

  Aissaoui, Hanaa ^a   Prévost, Célia ^a   Boucharaba, Ahmed ^b   Sanhadji, Kamel ^c   Bordet, Jean Claude ^a   Négrier, Claude ^a   Boukerche, Habib ^a  

^a University Lyon 1   (France)

^b EPFL   (Switzerland)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CYTOLOGY; DERMATOLOGY; ENZYME ACTIVITY; ENZYME INHIBITION; GENES; ONCOLOGY; PATHOLOGY; PIGMENTS; SIGNALING;

EXTRACELLULAR ENVIRONMENTS; MALIGNANT MELANOMA; MATRIX METALLOPROTEINASE-2; METASTATIC MELANOMA; PDZ BINDING MOTIF; SIGNALING PATHWAYS; THERAPEUTIC STRATEGY; TUMOR PROGRESSIONS;

CELL SIGNALING;

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8A; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PAXILLIN; PROTEIN CDC42; PROTEIN KINASE P60; PROTEINASE ACTIVATED RECEPTOR 1; RAC1 PROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNTENIN; THROMBIN; THROMBOPLASTIN; BLOOD CLOTTING FACTOR 7A; MMP2 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN TYROSINE KINASE; SDCBP PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CONTROLLED STUDY; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MDA 9 GENE; MELANOMA CELL; METASTASIS POTENTIAL; METASTATIC MELANOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR INVASION; 3T3 CELL LINE; ANIMAL; CELL MOTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; PDZ DOMAIN; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; FACTOR VIIA; FACTOR X; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; MELANOMA; MICE; NEOPLASM METASTASIS; NF-KAPPA B; NIH 3T3 CELLS; PAXILLIN; PDZ DOMAINS; PROTEIN BINDING; RAC1 GTP-BINDING PROTEIN; RECEPTOR, PAR-1; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SYNTENINS; UP-REGULATION;

EID: 84922375356     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.606913     Document Type: Article

References (53)

1. Lin, J. J., Jiang, H., and Fisher, P. B. (1998) Melanoma differentiation associated gene-9, MDA-9, is a human y interferon responsive gene. Gene 207, 105-110
2. Sarkar, D., Boukerche, H., Su, Z. Z., and Fisher, P. B. (2008) MDA-9/syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res. 68, 3087-3093
3. Beekman, J. M., and Coffer, P. J. (2008) The ins and out of syntenin, a mutifuctional intracellular adaptator protein. J. Cell Sci. 121, 1349-1355
4. Das, S. K., Bhutia, S. K., Kegelman, T. P., Peachy, L., Oyesanya, R. A., Dasgupta, S., Sokhi, U. K., Azab, B., Dash, R., Quinn, B. A., Kim, K., Barral, P. M., Su, Z. Z., Boukerche, H., Sarkar, D., and Fisher, P. B. (2012) MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front. Biosci. 17, 1-15
5. Dasgupta, S., Menezes, M. E., Das, S. K., Emdad, L., Janjic, A., Bhatia, S., Mukhopadhyay, N. D., Shao, C, Sarkar, D., and Fisher, P. B. (2013) Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin. Cancer Res. 19, 4621-4633
6. Boukerche, H., Su, Z. Z., Emdad, L., Baril, P., Balme, B., Thomas, L., Randolph, A., Valerie, K., Sarkar, D., and Fisher, P. B. (2005) MDA-9/syntenin: a positive regulator of melanoma metastasis. Cancer Res. 65, 10901-10911
7. Gangemi, R., Mirisola, V., Barisione, G., Fabbi, M., Brizzolara, A., Lanza, F., Mosci, C, Salvi, S., Gualco, M., Truini, M., Angelini, G., Boccardo, S., Cilli, M., Airoldi, I., Queirolo, P., Jager, M. J., Daga, A., Pfeffer, U., and Ferrini, S. (2012) MDA-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One 7, e29989
8. Boukerche, H., Su, Z. Z., Emdad, L., Sarkar, D., and Fisher, P. B. (2007) MDA-9/syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-κB. Cancer Res. 67, 1812-1822
9. Boukerche, H., Su, Z. Z., Prévot, C, Sarkar, D., and Fisher, P. B. (2008) MDA-9/syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc. Natl. Acad. Sci. U.S.A. 105, 15914-15919
10. Boukerche, H., Aissaoui, H., Prévost, C, Hirbec, H., Das, S. K., Su, Z. Z., Sarkar, D., and Fisher, P. B. (2010) Src kinase activation is mandatory for MDA-9/Syntenin-mediated activation of nuclear factor-κB. Oncogene29, 3054-3066
11. Bissell, M. J., and Radisky, D. (2001) Putting tumours in context. Nat. Rev. Cancer 1, 46-54
12. Falanga, A., Marchetti, M., and Vignoli, A. (2013) Coagulation and cancer: biological and clinical aspects. J. Thromb. Haemost. 11, 223-233
13. Bach, R. R. (1988) Initiation of coagulation by tissue factor. CRC Crit. Rev. Biochem. 23, 339-368
14. Hirano, K. (2007) The role of proteinase-activated receptors in the vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 27, 27-36
15. Kasthuri, R. S., Taubman, M. B., and Mackman, N. (2009) Role of tissue factor in cancer. J. Clin. Oncol. 27, 4834-4838
16. Rickles, F. R., Hair, G. A., Zeff, R. A., Lee, E., and Bona, R. D. (1995) Tissue factor expressionin human leukocytes and tumor cells. Thromb. Haemost. 74, 391-395
17. Depasquale, I., and Thompson, W. D. (2008) Prognosis in human melanoma PAR-1 expression is superior to other coagulation components and VEGF. Histopathology 52, 500-509
18. Hahn, N., Heiden, M., Seitz, R., and Salge-Bartels, U. (2012) Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion. J. Cancer Res. Clin. Oncol. 138, 695-703
19. Zacharski, L. R., Dunwiddie, C., Nutt, E. M., Hunt, J., and Memoli, V. A. (1991) Cellular localization of activated factor X by Xa-specific probes. Thromb. Haemost. 65, 545-548
20. Amarzguioui, M., Peng, Q., Wiiger, M. T., Vasovic, V., Babaie, E., Holen, T., Nesland, J. M., and Prydz, H. (2006) Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin. Cancer Res. 12, 4055-4061
21. Bromberg, M. E., Konigsberg, W. H., Madison, J. F., Pawashe, A., and Garen, A. (1995) Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. U.S.A. 92, 8205-8209
22. Mueller, B.M., Reisfeld, R. A., Edgington, T. S., and Ruf, W.(1992) Expression of tissue factor by melanoma promotes efficient hematogeneous metastasis. Proc. Natl. Acad. Sci. U.S.A. 89, 11832-11836
23. Riewald, M., and Ruf, W. (2001) Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc. Natl. Acad. Sci. U.S.A. 98, 7742-7747
24. Camerer, E., Huang, W., and Coughlin, S. R. (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by FVIIa. Proc. Natl. Acad. Sci. U.S.A. 97, 5255-5260
25. Rao, L. V., and Pendurthi, U. R. (2005) Tissue factor-factor VIIa signaling. Arterioscler. Thromb. Vasc. Biol. 25, 47-56
26. Ettelaie, C., Li, C., Collier, M. E., Pradier, A., Frentzou, G. A., Wood, C. G., Chetter, I. C., McCollum, P. T., Bruckdorfer, K. R., and James, N. J. (2007) Differential functions of tissue factor in the trans-activation of cellular signaling pathways. Atherosclerosis 194, 88-101
27. Bladbjerg, E. M., Overgaard, K., Gram, J., and Jespersen, J. (1995) The protein concentration of blood coagulation factor VII can be measured equally well in plasma in serum. Scand. J. Clin. Lab. Invest. 55, 267-271
28. Gnoni, G. V., Geelen, M. J., Bijleveld, C., Quagliariello, E., and van den Bergh, S. G. (1985) Short-term stimulation of lipogenesis by triiodothyronine in maintenance cultures of rat hepatocytes. Biochem. Biophys. Res. Commun. 128, 525-530
29. Hirbec, H., Perestenko, O., Nishimune, A., Meyer, G., Nakanishi, S., Henley, J. M., and Dev, K. K. (2002) The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs. J. Biol. Chem. 277, 15221-15224
30. Abouzahr-Rifai, S., Hasmim, M., Boukerche, H., Hamelin, J., Janji, B., Jalil, A., Kieda, C., Mami-Chouaib, F., Bertoglio, J., and Chouaib, S. (2008) Resistance of tumor cells to cytolytic T lymphocytes involves Rho-GTPases and focal adhesion kinase activation. J. Biol. Chem. 283, 31665-31672
31. Plantier, J. L., Rolli, V., Ducasse, C., Dargaud, Y., Enjolras, N., Boukerche, H., and Négrier, C. (2010) Activated factorX cleaves factor VIII at arginine 562, limiting its cofacor efficiency. J. Thromb. Haemost. 8, 286-293
32. Wildgoose, P., Kazim, A. L., and Kisiel, W. (1990) The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor. Proc. Natl. Acad. Sci. U.S.A. 87, 7290-7294
33. Pendurthi, U. R., Alok, D., and Rao, L. V. (1997) Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibrooblast cells: up-regulation of poly(A) polymerase. Proc. Natl. Acad. Sci. U.S.A.94, 12598-12603
34. Yamauchi, J., Miyamoto, Y., Kokubu, H., Nishii, H., Okamoto, M., Sugawara, Y., Hirasawa, A., Tsujimoto, G., and Itoh, H. (2002) Endothelin suppresses cell migration via the JNK signaling pathway in a manner dependent upon Src kinase, Rac1, and Cdc42. FEBS Lett. 527, 284-288
35. Fanger, G. R., Johnson, N. L., and Johnson, G. L. (1997) MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J. 16, 4961-4972
36. Huang, C, Rajfur, Z., Borchers, C, Schaller, M. D., and Jacobson, K. (2003) JNK phosphorylates paxillin and regulates cell migration. Nature 424, 219-223
37. Deakin, N. O., and Turner, C. E. (2008) Paxillin comes of age. J. Cell Sci. 121, 2435-2444
38. Jiang, X., Bailly, M. A., Panetti, T. S., Cappello, M., Konigsberg, W. H., and Bromberg, M. E. (2004) Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. J. Thromb. Haemost. 2, 193-101
39. McEachron, T. A., Pawlinski, R., Richards, K. L., Church, F. C, and Mackman, N. (2010) Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis. Blood 116, 5037-5044
40. Shi, X., Gangadharan, B., Brass, L. F., Ruf, W., and Mueller, B. M. (2004) Protease-activated receptors (PAR-1 and PAR-2) contributes to tumor cell motility and metastasis. Mol. Cancer Res. 2, 395-402
41. O'Brien, P. J., Prevost, N., Molino, M., Hollinger, M. K., Woolkalis, M. J., Woulfe, D. S., and Brass, L. F. (2000) Thrombin responses in human endothelial cells: contribution from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275, 13502-13509
42. Zacharski, L. R., Wojtukiewicz, M. Z., Costantini, V., Ornstein, D. L., and Memoli, V. A. (1992) Pathways of coagulation/fibrinolysis activation in malignancy. Semin. Thromb. Hemost. 18, 104-116
43. Altieri, D. C, and Edgington, T. S. (1988) The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem. 263, 7007-7015
44. Koizume, S., Jin, M. S., Miyagi, E., Hirahara, F., Nakamura, Y., Piao, J. H., Asai, A., Yoshida, A., Tsuchiya, E., Ruf, W., and Miyagi, Y. (2006) Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res. 66, 9453-9460
45. Velasco-Velázquez, M. A., Salinas-Jazmín, N., Mendoza-Patino, N., and Mandoki, J. J. (2008) Reduced paxillin expression contributes to the anti-metastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells. Cancer Cell Int. 8, 8
46. Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., and Lacal, J. C. (1997) Activation of the nuclear-κB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11, 463-475
47. Coso, O. A., Chiariello, M., Yu, J. C, Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J. S. (1995) The Small GTP-binding proteins Rac1 and Cdc42 regulates the activity of the JNK/SAPK signaling pathway. Cell 81, 1137-1146
48. Conn, E. M., Madsen, M. A., Cravatt, B. F., Ruf, W., Deryugina, E. I., and Quigley, J. P. (2008) Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J. Biol. Chem. 283, 26518-26527
49. Jung, I. D., Lee, J., Yun, S. Y., Park, C. G., Choi, W. S., Lee, H. W., Choi, O. H., Han, J. W., and Lee, H. Y. (2002) Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Lett. 532, 351-366
50. Durrant, J. D., de Oliveira, C. A., and McCammon, J. A. (2010) Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors. J. Mol. Recognit. 23, 173-182
51. Green, T. P., Fennell, M., Whittaker, R., Curwen, J., Jacobs, V., Allen, J., Logie, A., Hargreaves, J., Hickinson, D. M., Wilkinson, R. W., Elvin, P., Boyer, B., Carragher, N., Plé, P. A., Bermingham, A., Holdgate, G. A., Ward, W. H, Hennequin, L. F., Davies, B. R., and Costello, G. F. (2009) Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Mol. Oncol. 3, 248-261
52. Silini, A., Ghilardi, C, Ardinghi, C, Bernasconi, S., Oliva, P., Carraro, F., Naldini, A., Bani, M. R., and Giavazzi, R. (2010) Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype. Clin. Exp. Metastasis 27, 43-53
53. Villares, G. J., Dobroff, A. S., Wang, H, Zigler, M., Melnikova, V. O., Huang, L., and Bar-Eli, M. (2009) Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res. 69, 6730-6737